Skip to main content

Advertisement

SpringerLink
Log in

Endovascular Thrombolysis Using Monteplase for Non-chronic Deep Venous Thrombosis

  • Technical Note
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

This study was designed to evaluate the usefulness of endovascular thrombolysis using monteplase for deep venous thrombosis (DVT). Between December 2005 and October 2009, at our institution nine endovascular thrombolysis treatments with monteplase were performed for symptomatic DVT in eight patients (6 women, 2 men; mean age, 56 (range, 15–80) years). In all, systemic anticoagulation administered by the peripheral intravenous route with heparin and/or thrombolysis with urokinase followed by anticoagulation with orally administered warfarin had been performed, and subsequently six endovascular treatments without monteplase were administered. However, DVT persisted, and endovascular treatments with monteplase were tried. In six (67%) of the nine procedures, DVT completely or almost completely disappeared after endovascular thrombolysis with monteplase. Mean dose of monteplase used was 2,170,000 IU. There was only one procedure-related complication. In one patient, just after thrombolysis with monteplase, bleeding at the puncture site and gingival bleeding occurred. Bleeding was stopped by manual astriction only. Endovascular thrombolysis with monteplase may be an effective treatment for DVT, even in cases resistant to traditional systemic anticoagulation and thrombolysis and endovascular procedures without monteplase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA Jr, Caldwell MD et al (1997) Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 8:405–418

    Article  CAS  PubMed  Google Scholar 

  2. Sharafuddin MJ, Sun S, Hoballah JJ, Youness FM, Sharp WJ, Roh BS (2003) Endovascular management of venous thrombotic and occlusive diseases of the lower extremities. J Vasc Interv Radiol 14:405–423

    PubMed  Google Scholar 

  3. Meissen MW, Seabrook GR, Meissener MH et al (1999) Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 211:39–49

    Google Scholar 

  4. Yamagami T, Kato T, Iida S, Hirota T, Nishimura T (2005) Gunther tulip inferior vena cava filter placement during treatment for deep venous thrombosis of the lower extremity. Cardiovasc Interv Radiol 28:442–453

    Article  Google Scholar 

  5. Vedantham S, Thorpe PE, Cardella JF, Grassi CJ, Patel NH, Ferral H et al (2006) Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 17:435–448

    Article  PubMed  Google Scholar 

  6. Semba CP, Bakal CW, Calis KA et al (2000) Alteplase as an alternative to urokinase. Advisory panel on catheter-directed thrombolysis. J Vasc Interv Radiol 11:279–287

    Article  CAS  PubMed  Google Scholar 

  7. Benenati J, Shlansky-Goldberg R, Meglin A et al (2001) Thrombolytic and antiplatelet therapy in peripheral vascular disease with the use of reteplase and/or abciximab. The SCVIR Consultants’ Conference; May 22, 2000, Orlando FL. Society for Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 12:795–805

  8. Shortell CK, Queiroz R, Johansson M et al (2001) Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion. J Vasc Surg 34:854–859

    Article  CAS  PubMed  Google Scholar 

  9. Sugimoto K, Hofmann LV, Razavi MK et al (2003) The safety and efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusion. J Vasc Surg 37:512–517

    Article  PubMed  Google Scholar 

  10. Elliot MS, Immelman EJ, Jeffery P et al (1979) A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg 66:838–843

    Article  CAS  PubMed  Google Scholar 

  11. Akesson H, Brudin L, Dahlstrom JA et al (1990) Venous function assessed during a 5-year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 4:43–48

    Article  CAS  PubMed  Google Scholar 

  12. AbuRahma AF, Perkins SE, Wulu JT et al (2001) Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 233:752–760

    Article  CAS  PubMed  Google Scholar 

  13. Roy S, Laerum F (1999) Transcatheter aspiration: the key to successful percutaneous treatment of deep venous thrombosis? Acad Radiol 6:730–735

    Article  CAS  PubMed  Google Scholar 

  14. Nazarian GK, Bjarnason H, Dietz CA Jr et al (1996) Iliofemoral venous stenoses: Effectiveness of treatment with metallic endovascular stents. Radiology 200:193–199

    CAS  PubMed  Google Scholar 

  15. Verstraete M (2000) Third-generation thrombolytic drugs. Am J Med 109:52–58

    Article  CAS  PubMed  Google Scholar 

  16. Grunwald MR, Hofmann LV (2004) Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol 15:347–352

    PubMed  Google Scholar 

  17. Suzuki S, Saito M, Suzuki N et al (1991) Thrombolytic properties of a novel modified human tissue-type plasminogen activator (E 6010): a bolus injection of E 6010 has equivalent potency of lysing young and aged canine coronary thrombi. J Cardiovasc Pharmacol 17:738–746

    Article  CAS  PubMed  Google Scholar 

  18. Kawai C, Hosoda S, Kimata S et al (1994) Coronary thrombolysis in acute myocardial infarction of E6010 (novel modified t-PA): a multicenter, double-blind, dose-findings study. Jpn Pharmacol Ther 22:3925–3950

    Google Scholar 

  19. Kawai C, Yui Y, Hosoda S et al (on behalf of the E 6010 Study Group) (1997) A prospective, randomized, double-blind multicenter trial of single bolus injection of the novel modified t-PA E 6010 in the treatment of acute myocardial infarction: comparison with native t-PA. J Am Coll Cardiol 29:1447–1453

    Google Scholar 

  20. Inoue T, Nishiki R, Kageyama M et al (2005) Therapeutic potential of monteplase in acute myocardial infarction. Am J Cardiovasc Drugs 5:225–231

    Article  CAS  PubMed  Google Scholar 

  21. Hokimoto S, Saito T, Oshima S, Ogawa H (2008) Initial and mid-term outcomes of pulse infusion thrombolysis using a unique pump system and stent placement for deep vein thrombosis. Inter Med 47:1663–1667

    Article  Google Scholar 

  22. Yamamoto T, Murai K, Tokita Y, Kato K, Iwasaki Y, Sato N, Tajima H, Mizuno K, Tanaka K (2009) Thrombolysis with a novel modified tissue-type plasminogen activator, monteplase, combined with catheter-based treatment for major pulmonary embolism. Circ J 73:106–110

    Article  PubMed  Google Scholar 

Download references

Conflicts of Interest Statement

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-chou, Kawaramachi-Hirokoji, Kamigyo-Ku, Kyoto, 602-8566, Japan

    Takuji Yamagami, Rika Yoshimatsu, Osamu Tanaka, Hiroshi Miura & Tsunehiko Nishimura

Authors
  1. Takuji Yamagami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rika Yoshimatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Osamu Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tsunehiko Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takuji Yamagami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamagami, T., Yoshimatsu, R., Tanaka, O. et al. Endovascular Thrombolysis Using Monteplase for Non-chronic Deep Venous Thrombosis. Cardiovasc Intervent Radiol 33, 1223–1229 (2010). https://doi.org/10.1007/s00270-010-9856-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-010-9856-4

Keywords

Search

Navigation